Rahul Samant
Has grant
Group Leader
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Harnessing cell-specific proteostasis vulnerabilities to promote lifelong health
Open Date: 2025-09-30
Close Date: 2028-09-30
Grant: Open
Signalling: Explaining the breakdown in proteostasis across the lifecourse
Open Date: 2024-03-31
Close Date: 2028-03-30
Grant: Close
Interspecies cell fusions to dissect the species-specific rates of development
Open Date: 2023-11-20
Close Date: 2025-05-18
Grant: Close
Unpicking the role of cellular stress responses in the efficacy of novel senolytic agents
Open Date: 2022-10-02
Close Date: 2026-10-01
Grant: Close
Spatial protein quality control (PQC) in mammalian cells: from cellular structures to mechanisms
Open Date: 2015-05-01
Close Date: 2018-04-30
Positions (1)
Rahul Samant
Babraham Institute
9 months ago
The Samant Lab at the Babraham Institute is seeking a postdoctoral researcher to join their team investigating the mechanisms by which cellular senescence and proteostasis dysregulation contribute to tissue ageing. The research will utilize advanced 3D models, such as organoids and air-liquid interfaces (ALIs), alongside cutting-edge imaging techniques to explore the molecular and cellular pathways involved in ageing and age-related diseases. The lab's interests span ubiquitin biology, proteostasis, proteomics, and the broader context of cellular ageing and senescence. The successful candidate will have a PhD in a relevant biological or biomedical discipline and demonstrated expertise in 3D cell culture models and advanced imaging. Experience with proteomics or molecular biology techniques is advantageous. The Babraham Institute provides a collaborative and well-resourced environment for research in the life sciences, with a focus on fundamental mechanisms of health and disease. This is a paid postdoctoral position, with funding details to be confirmed. The application deadline is 25th February 2026. Interested candidates should apply through the Babraham Institute's online portal and are encouraged to contact Dr. Rahul Samant for informal inquiries. This opportunity is ideal for researchers passionate about ageing, proteostasis, and innovative cell biology approaches.
9 months ago
Articles (4)
Post-translational modification with chains of the 76-amino-acid protein ubiquitin (‘poly-ubiquitylation’) confers diverse fates to the targeted protein and non-protein substrates, including degradation, intracellular trafficking, and signal transduction. Despite being one of the most frequent modifications, the complexity of poly-ubiquitin chains adds methodological challenges to their characterization. Trypsin-resistant tandem-ubiquitin-binding entities (trTUBEs), engineered from natural ubiquitin-binding domains, can capture intact poly-ubiquitylated proteins with high cumulative avidity. However, such approaches have suffered from considerable co-eluting contaminants in proteomics applications. Here, we introduce an optimized trTUBE-based method for poly-ubiquitylated proteome purification, drastically depleting non-ubiquitylated protein contaminants and mono-ubiquitylated proteins. The method, termed Ubiquitylomics by Stringent, Cleavable, Affinity-based Proteome Extraction (Ubi-SCAPE), offers a streamlined and reproducible (median R 2 > 0.98; CV < 8%) means of characterizing the poly-ubiquitylome. Over 7,800 poly-ubiquitylated proteins and 8,500 ubiquitin-modified peptides (diGly) were quantified with Ubi-SCAPE at a throughput of 40 samples per day, as well as over 6,000 from an equivalent of 33 μg unstressed cell lysate. Upon acute stress by heat-shock, we identified 2,700 proteins and 8,000 diGly peptides with increased poly-ubiquitylation—offering similar biological insight as with far more material-, labor-, and cost-intensive peptide-based ubiquitin enrichment methods. Ubi-SCAPE therefore provides a simple and effective means of comprehensively quantifying a selective-enriched poly-ubiquitylome. GRAPHICAL ABSTRACT
Year:
2026
Year:
2025
Healthy protein homeostasis (‘proteostasis’) relies on tightly-regulated protein quality-control (PQC) circuits that co-ordinate sequestration and clearance of potentially toxic aggregation-prone proteins, arising from various internal or external stress throughout an organism’s lifespan. At the protein level, proteotoxic stress responses typically involve extensive poly-ubiquitylation and sequestration of aggregation-prone proteins and PQC factors into various protective cytoplasmic and nuclear granules. However, much of our current understanding regarding this aspect of stress responses in humans stems from research in proliferating cells—despite growing evidence that stress responses vary considerably at the transcriptional level across cell proliferation states. Here, we show that the senescent cellular state—considered a major contributor to ageing-associated degeneration due to a chronic inflammatory phenotype—re-wires PQC and expels the misfolded protein load to mitigate proteotoxic stresses. Starting with a multi-dimensional transcriptomics and proteomics approach for measuring levels of total, poly-ubiquitylated, and granule-forming proteins, we have discovered a clear point of divergence between senescent and proliferating or quiescent human cell states in their responses to proteotoxic stress. Although the proteins that were poly-ubiquitylated and degraded during stress were largely conserved across states, the stress-induced sedimentation of a large number of disease-associated RNA-binding proteins (including TDP-43) was impaired only in the senescent state. Strikingly, TDP-43, as well as several other misfolded proteins, were actively secreted through the endo-lysosomal system by a diverse range of senescent cells during acute or chronic stress, through a process that requires the vesicle-associated HSP70 co-chaperone DNAJC5—an established risk factor for several neurodegenerative diseases. Misfolded protein secretion could be rescued by increasing intracellular HSP levels in ‘shallow’ but not ‘deep’ senescence, suggesting that secretion is a proteostatic adaptation that becomes less reversible over time. Our findings reveal an unappreciated aspect of the senescent-cell secretory phenotype, which may have important consequences for the non-cell-autonomous impact of senescence at the level of tissue resilience and frailty.
Year:
2025
Skeletal muscle is a highly adaptable tissue, finely tuned by various physiological and pathological factors. Whilst the pivotal role of skeletal muscle in overall health is widely acknowledged, unravelling the underlying molecular mechanisms poses ongoing challenges. Protein ubiquitylation, a crucial post‐translational modification, is involved in regulating most biological processes. This widespread impact is achieved through a diverse set of enzymes capable of generating structurally and functionally distinct ubiquitin modifications on proteins. The complexity of protein ubiquitylation has presented significant challenges in not only identifying ubiquitylated proteins but also characterising their functional significance. Mass spectrometry enables in‐depth analysis of proteins and their post‐translational modification status, offering a powerful tool for studying protein ubiquitylation and its biological diversity: an approach termed ubiquitylomics. Ubiquitylomics has been employed to tackle different perspectives of ubiquitylation, including but not limited to global quantification of substrates and ubiquitin linkages, ubiquitin site recognition and crosstalk with other post‐translational modifications. As the field of mass spectrometry continues to evolve, the usage of ubiquitylomics has unravelled novel insights into the regulatory mechanisms of protein ubiquitylation governing biology. However, ubiquitylomics research has predominantly been conducted in cellular models, limiting our understanding of ubiquitin signalling events driving skeletal muscle biology. By integrating the intricate landscape of protein ubiquitylation with dynamic shifts in muscle physiology, ubiquitylomics promises to not only deepen our understanding of skeletal muscle biology but also lay the foundation for developing transformative muscle‐related therapeutics. This review aims to articulate how ubiquitylomics can be utilised by researchers to address different aspects of ubiquitylation signalling in skeletal muscle. We explore methods used in ubiquitylomics experiments, highlight relevant literature employing ubiquitylomics in the context of skeletal muscle and outline considerations for experimental design.
Year:
2024
Collaborators (5)
Simon Andrews
Head of Bioinformatics
Babraham Institute
Yu-Chiang Lai
University of Birmingham
Paul Clarke
Team Leader
Institute of Cancer Research
Matthias Trost
Professor of Proteomics
Newcastle University
Tatyana A Shelkovnikova
Senior Research Fellow
University of Sheffield
Make your next move.
Prepare your application
Review drafts before you send them.